Compounds > bendamustine hydrochloride
Page last updated: 2024-08-25

bendamustine hydrochloride and Sjogren's Syndrome

bendamustine hydrochloride has been researched along with Sjogren's Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demaria, L; Frenzel, L; Henry, J; Hermine, O; Mariette, X; Nocturne, G; Seror, R1
Abrisqueta, P; Bosch, F; Martínez, F; Pardos-Gea, J; Santamaría, A1

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Sjogren's Syndrome

ArticleYear
Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS).
    British journal of haematology, 2019, Volume: 184, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Retrospective Studies; Rituximab; Sjogren's Syndrome

2019
Acquired von Willebrand syndrome in a patient with small lymphocytic lymphoma and Sjögren's syndrome: which associated condition should be prioritized?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:5

    Topics: Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Immunological; Bendamustine Hydrochloride; Female; Hemorrhage; Humans; Immunoglobulins; Leukemia, Lymphocytic, Chronic, B-Cell; Rituximab; Sjogren's Syndrome; von Willebrand Diseases

2019